Company Description
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.
Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system.
In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing.
The company is headquartered in Toronto, Canada.
| Country | Canada |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 292 |
| CEO | Rajiv Kanishka De Silva |
Contact Details
Address: 235 Yorkland Boulevard, Suite 900 Toronto, ON M2J 4Y8 Canada | |
| Phone | 877 848 8430 |
| Website | venus.ai |
Stock Details
| Ticker Symbol | VERO |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001409269 |
| CUSIP Number | 92332W303 |
| ISIN Number | US92332W3034 |
| Employer ID | 06-1681204 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Rajiv Kanishka Liyanaarchchie De Silva | Chief Executive Officer and Director |
| Ross J. Portaro | Executive Vice President of Commercial Strategy and Head of Venus Hair |
| Domenic Della Penna C.P.A. | Executive Vice President and Chief Financial Officer |
| Michael Mandarello | Chief Legal Officer, Head of Strategy and Operations |
| Anna Georgiadis | Chief Human Resources Officer |
| Melissa Kang | Chief Product Officer |
| Joyce Morris | Head of Sales - Canada |
| Ognjen Petrovic | Head of Research & Development, Robotics, Software |
| Cliff Oostman | Head of Research & Development, Robotics, Hardware |
| Jesus Alvarez-Quintero | Head of Sales - LATAM |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 2, 2025 | SCHEDULE 13D/A | Filing |
| Jul 1, 2025 | 8-K | Current Report |
| Jun 27, 2025 | SCHEDULE 13D/A | Filing |
| Jun 26, 2025 | 8-K | Current Report |
| Jun 20, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Jun 13, 2025 | SCHEDULE 13G | Filing |
| Jun 12, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jun 11, 2025 | SCHEDULE 13D/A | Filing |
| Jun 11, 2025 | SCHEDULE 13G/A | Filing |
| Jun 11, 2025 | SCHEDULE 13G/A | Filing |